课题基金 / 基金详情

Identification of Risk Genes Supplement

Identification of Risk Genes Supplement
风险基因识别补充
批准号:
10598757
负责人:
Yun Freudenberg-Hua
金额:
$12.22万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-08-01 至 2023-10-31

项目摘要

项目成果

Yun Freudenberg-Hua的其他基金

相似基金

相关文献

中文摘要
翻译
摘要 晚发性阿尔茨海默病(AD)是一种常见的破坏性疾病, 估计遗传力。识别AD的风险基因有可能进一步我们的研究。 了解疾病的机制和修改因素,从而导致发展 有效的治疗。尽管在40多个国家中发现了常见的遗传风险变异, 虽然与AD相关的基因,但大部分遗传性仍然无法解释。这可能是由于 存在许多罕见的风险变异,无法在全基因组关联中识别 问题研究因此,需要通过基因组来评估罕见遗传变异的影响, 测序与异质人群相比,在一个 德系犹太人(AJ)血统的遗传同质创始人人口减少 统计噪声,从而增加统计功率。此外,与典型对照相比, 年龄在60岁到80岁之间的人可能在以后的年龄发展为AD,认知健康的百岁老人代表了 AD的真正控制。因此,比较AD病例的全基因组测序数据和 AJ祖先的百岁老人控制可以提供对AD中高影响罕见变体的见解。 博士Yun Freudenberg-Hua是一位医生数据科学家,在临床老年医学领域拥有专业知识。 精神病学和临床痴呆表型。她对AD的遗传学有浓厚的兴趣, 分析基因数据的能力。K 08奖的延期将为她提供受保护的 研究时间来完成她正在进行的全基因组测序数据的分析,这是 受到COVID-19大流行的干扰。在延长期内,她将确定 通过整合1)功能编码变体的知识,2)选择功能变体, 功能性非编码变异体; 3)应用新的生物信息学方法研究AD相关基因组 和统计方法。她将在艾莉森博士的指导下实现这些目标 Goate并继续她申请独立NIH资助的计划。 目标是检验罕见功能变体在特定基因集中富集的假设 AD患者中。将包括推定的功能编码和非编码变体, 聚合分析应用一种新的机器学习方法REGENIE。我们将扩大 该分析包括来自阿尔茨海默病测序的AJ全基因组子集 项目在特定途径中突出显示的罕见遗传风险变异可以转化为 AD预测和治疗剂的开发。本项目产生的数据 应该允许Freudenberg-Hua博士竞争R 01资金,以研究 遗传风险、生物标志物和复杂临床表型之间的多维相互作用 并找出可以改变的因素。
英文摘要
Abstract Late onset Alzheimer’s Disease (AD) is a common and devastating disease with a high estimated heritability. Identification of risk genes for AD has the potential to further our understanding of disease mechanism and modifying factors, thus leading to development of effective treatments. Despite the identification of common genetic risk variants in more than 40 genes associated with AD, much of the heritability remains unexplained. This may be due to the presence of many rare risk variants, which cannot be identified in genome wide association studies. Therefore, evaluating the impact of rare genetic variants is required through genome sequencing. Compared to a heterogeneous population, conducting genetic studies in a genetically homogeneous founder population of Ashkenazi Jewish (AJ) ancestry reduces statistical noise, thereby increasing statistical power. Furthermore, compared to typical controls aged 60s to 80s, who may develop AD at a later age, cognitively healthy centenarians represent true controls for AD. Thus, comparing whole genome sequencing data of AD cases and centenarian controls of AJ ancestry could offer insights on high impact rare variants in AD. Dr. Yun Freudenberg-Hua is a physician data scientist with expert knowledge in clinical geriatric psychiatry and clinical dementia phenotypes. She has a keen interest in genetics for AD and the ability to analyze genetic data. The extension of the K08 award will provide her with protected research time to complete her ongoing analysis of whole genome sequencing data, which was disrupted by the COVID-19 pandemic. During the extension period, she will identify putative functional variants by integrating 1) knowledge of functional coding variants, 2) selection of functional non-coding variants, and 3) gene sets involved in AD by applying novel bioinformatics and statistical methods. She will accomplish these goals under the mentorship of Dr. Alison Goate and continue her plan to apply for independent NIH funding. The goal is to test the hypothesis that rare functional variants are enriched in specific gene sets among AD patients. Putative functional coding and non-coding variants will be included for aggregation analysis by applying a novel machine-learning method REGENIE. We will expand the analysis to include AJ whole genome subsets from the Alzheimer’s Disease Sequencing Project. The rare genetic risk variants highlighted in specific pathways can be translated into both AD prediction and development of therapeutic agents. The data generated in this project should allow Dr. Freudenberg-Hua to compete for R01 funding to investigate the multidimensional interplay between genetic risks, biomarkers, and complex clinical phenotypes of dementia and to identify factors that are modifiable.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
Beyond standard pipeline and p < 0.05 in pathway enrichment analyses.
途径富集分析中的标准管道和p <0.05。
DOI: 10.1016/j.compbiolchem.2021.107455
发表时间: 2021-06
期刊: Computational biology and chemistry
影响因子: 3.1
作者: []
通讯作者:
DOI: 10.3389/fmed.2018.00108
发表时间: 2018
期刊: Frontiers in medicine
影响因子: 3.9
作者: [Freudenberg-Hua Y, Li W, Davies P]
通讯作者: Davies P
DOI: 10.1371/journal.pone.0258916
发表时间: 2021
期刊: PloS one
影响因子: 3.7
作者: [Austria B, Haque R, Mittal S, Scott J, Vengassery A, Maltz D, Li W, Greenwald B, Freudenberg-Hua Y]
通讯作者: Freudenberg-Hua Y
Psychotropic Medication Use Is Associated With Greater 1-Year Incidence of Dementia After COVID-19 Hospitalization.
精神药物的使用与COVID-19-19 HOSIPAIDE后的痴呆症发生率更高有关。
DOI: 10.3389/fmed.2022.841326
发表时间: 2022
期刊: Frontiers in medicine
影响因子: 3.9
作者: [Freudenberg-Hua Y, Makhnevich A, Li W, Liu Y, Qiu M, Marziliano A, Carney M, Greenwald B, Kane JM, Diefenbach M, Burns E, Koppel J, Sinvani L]
通讯作者: Sinvani L
Identification of Risk Genes by Comparing Whole Genome Sequences of Alzheimer's Disease Patients and Cognitively Healthy Centenarians
Identification of Risk Genes by Comparing Whole Genome Sequences of Alzheimer's Disease Patients and Cognitively Healthy Centenarians
海外基金